Study to Assess PK, Safety and Tolerability Early in Healthy Subjects
Clinical trial NCT06388772 · COMPLETED
Trial details
- NCT number
- NCT06388772
- Sponsor
- Changzhou Qianhong Bio-pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-05
- Primary completion
- 2022-07-22
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.